Cargando…

P009 Australian consultant pharmacists’ potential roles in sleep health care - Exploring a new avenue for improving the management of insomnia

BACKGROUND: Insomnia is a highly prevalent sleep disorder and the first-line recommended treatment is cognitive behavioural therapy. However, there is persistent use of pharmacotherapy, mainly, sedative-hypnotics. Consultant pharmacists can provide medication review services for patients on polyphar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basheti, M, Tran, M, Wong, K, Gordon, C, Grunstein, R, Saini, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109017/ http://dx.doi.org/10.1093/sleepadvances/zpab014.058

Ejemplares similares

P057 Exploring the ‘Pharmacist Role’ in Insomnia Management and Care Provision: A Scoping Review
por: Basheti, M, et al.
Publicado: (2023)

P016 Evaluating the effectiveness of an interactive educational intervention on sleep health for second-year pharmacy students
por: Basheti, M, et al.
Publicado: (2022)

P015 Improving sleep health management in primary care: A potential role for community nurses?
por: Basheti, M, et al.
Publicado: (2022)

P102 Sleep health management practices in Australian residential aged care facilities: The perspective of registered nurses
por: Chen, E, et al.
Publicado: (2022)

P009 The effects of low-dose morphine on sleep and breathlessness in chronic obstructive pulmonary disease
por: Altree, T, et al.
Publicado: (2022)

P053 Management of insomnia by Australian psychologists
por: Haycock, J, et al.
Publicado: (2021)

P066 A randomised, double-blind, placebo-controlled, single-dose, crossover, pilot study investigating the effects of cannabinol (CBN) 30 mg and 300 mg on sleep architecture and next-day function in insomnia disorder
por: Lavender, I, et al.
Publicado: (2022)

P044 Primary care management of chronic insomnia by general practitioners: an Australian perspective
por: Grivell, N, et al.
Publicado: (2021)

O008 Embedding digital sleep health into primary care practice: perspectives of general practitioners, nurses, and pharmacists
por: Cheung, J, et al.
Publicado: (2021)

P092 Improving Postgraduate Psychology Students’ Sleep and Insomnia Knowledge with a Sleep Education Workshop
por: Meaklim, H, et al.
Publicado: (2021)

P052 Treatment preferences and help seeking behaviours of Australian adults with insomnia symptoms
por: Haycock, J, et al.
Publicado: (2022)

P009. A case of new daily persistent headache treated with botulinum toxin type A
por: Trucco, Marco, et al.
Publicado: (2015)

P009: Epidemiology, microbiology and outcome of community-οnset gram-negative bacteremias in a Greek University Hospital
por: Gikas, A, et al.
Publicado: (2013)

P086 The insomnia severity index is related to the respiratory arousal threshold in people with Co-Morbid Insomnia and Sleep Apnoea (COMISA)
por: Zheng, J, et al.
Publicado: (2022)

P129 A substantial percentage of patients with Chronic Insomnia do not appreciably increase Total Sleep Time after Cognitive Behavioural Therapy for Insomnia
por: Scott, H, et al.
Publicado: (2021)

Insomnia management; don't sleep on it
por: Donnelly, Maria, et al.
Publicado: (2021)

P009 Time spent with SpO2 below 90% during Sleep is Greater in Children with Down syndrome and OSA than in Typically Developing Children
por: Walter, L, et al.
Publicado: (2023)

P114 The effect of light interventions on sleep macro- and micro-architecture in sleep and circadian rhythm disorders: A scoping review
por: Pun, T, et al.
Publicado: (2021)

P018 The effects of zopiclone on sleep spindles in obstructive sleep apnea: A randomized placebo-controlled trial
por: Carter, S, et al.
Publicado: (2021)

P143 Sleep-dependent declarative memory consolidation and NREM sleep EEG oscillations in older adults with obstructive sleep apnea
por: Teh, J, et al.
Publicado: (2021)

The role of complement in ATTR amyloidosis: a new therapeutic avenue?
por: Panayiotou, Elena, et al.
Publicado: (2015)

P-009: IDENTIFYING BARRIERS FOR PATIENTS WITH SICKLE CELL DISEASE TO ACCESS TREATMENT WITH HYDROXYUREA – A QUALITATIVE ANALYSIS OF THE SUPPLY CHAIN IN GHANA
por: S., GRAVEN, et al.
Publicado: (2022)

P046 More teaching, less sleeping: The impact of stressful periods of the school year on the sleep of Australian schoolteachers
por: Friday, M, et al.
Publicado: (2021)

P120 Incidence, persistence and remission of co-morbid insomnia and sleep apnea (COMISA) over time in the Wisconsin Sleep Cohort data
por: Sweetman, A, et al.
Publicado: (2022)

P065 A Comparison of Two Obesity Related Hypoventilation Disorders – Impact on Sleep, Quality of Life and Neurocognitive Outcomes and the Effects of PAP Therapy
por: Zheng, Y, et al.
Publicado: (2023)

O028 Effectiveness of digital brief behavioural therapy for insomnia with wearable technology: pilot randomized controlled trial
por: Gordon, C, et al.
Publicado: (2021)

P084 Is Cognitive Behaviour Therapy for insomnia (CBTi) responsiveness a function of objective sleep efficiency rather than objective sleep duration?
por: Lovato, N, et al.
Publicado: (2021)

A Comparison of Screening Methods for Sleep Disorders in Australian Community Pharmacies: A Randomized Controlled Trial
por: Fuller, Joanne M., et al.
Publicado: (2014)

P018 Effect of CBT-I on sleep-wake state discrepancy in individuals with co-morbid insomnia and sleep apnoea: A randomised controlled trial
por: Bensen-Boakes, D, et al.
Publicado: (2022)

P139 Co-morbid insomnia and sleep apnoea (COMISA): Identifying patients that are responsive to continuous positive airway pressure therapy
por: Sweetman, A, et al.
Publicado: (2021)

P127 Study protocol for examining the role of REM sleep in trauma-recovery mechanisms: REM fragmentation and fear inhibition in adults with insomnia disorder before and after cognitive behavioural therapy for insomnia (CBT-I)
por: Vuong, V, et al.
Publicado: (2022)

P073 Co-morbid insomnia and obstructive sleep apnoea is associated with all-cause mortality and cardiovascular event risk
por: Lechat, B, et al.
Publicado: (2021)

O009 Are there Differences in SpO2 Recordings from Two Oximeters on the same hand during an Overnight Sleep Study Significant?
por: McDermott, E, et al.
Publicado: (2023)

P056 REducing Sleep Apnoea for the PrEvention of Dementia (REShAPED): The protocol of a multi-site feasibility randomised controlled trial
por: Hoyos, C, et al.
Publicado: (2022)

P037 Indigenous Australians’ conceptualisation of sleep health differs from western interpretations
por: Fatima, Y, et al.
Publicado: (2021)

P130 The lived experience of shift work, sleep loss and fatigue in Australian paramedics
por: Wanstall, S, et al.
Publicado: (2022)

P050 Familiar locations and new locations: sleep’s role in the consolidation of spatial navigation information using a novel virtual Morris water maze task in older adults with mild cognitive impairment
por: Haroutonian, C, et al.
Publicado: (2021)

P119 Co-morbid insomnia is associated with worse health, and lower CPAP recommendation rates and nightly use in people with sleep apnoea
por: Tan, D, et al.
Publicado: (2022)

P076 Safety of higher doses of melatonin in adults: A systematic review and meta-analysis
por: Menczel Schrire, Z, et al.
Publicado: (2022)

P001 Safety, tolerability, and efficacy of 1 month of atomoxetine plus oxybutynin in obstructive sleep apnoea
por: Aishah, A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0qnia7h3l121ma6no81973d5mn